Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM)
Duygu Sari(Sağlık Bilimleri Üniversitesi), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Nikolaos Patsoukis(Beth Israel Deaconess Medical Center), Esther M. Lafuente(Universidad Complutense de Madrid), Yavuz F. Yazicioglu(University of Oxford), Álvaro Torres-Gómez(Research Institute Hospital 12 de Octubre), Anthos Christofides(Beth Israel Deaconess Medical Center)
Cited by 9
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
|Science|1993|914
The complex role of tumor-infiltrating macrophages
|Nature Immunology|2022|859